FDA Inspection 1303322 — Pharmalogic Los Angeles, LLC

Pharmalogic Los Angeles, LLC — FEI 3029778311

The FDA completed an inspection of Pharmalogic Los Angeles, LLC on February 5, 2026 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 5, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
1776021 CFR 212.20(c)Specifications and processes